242 related articles for article (PubMed ID: 32984525)
1. RECURRENT PITUITARY APOPLEXY IN AN ADENOMA WITH SWITCHING PHENOTYPES.
Brown TV; Cheesman KC; Post KD
AACE Clin Case Rep; 2020; 6(5):e221-e224. PubMed ID: 32984525
[TBL] [Abstract][Full Text] [Related]
2. Sparsely Granulated Corticotroph Pituitary Macroadenoma Presenting With Pituitary Apoplexy Resulting in Remission of Hypercortisolism.
Liu T; Rossiter JP; Houlden RL; Awad S
AACE Clin Case Rep; 2022; 8(4):166-170. PubMed ID: 35959088
[TBL] [Abstract][Full Text] [Related]
3. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
4. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence.
Strickland BA; Shahrestani S; Briggs RG; Jackanich A; Tavakol S; Hurth K; Shiroishi MS; Liu CJ; Carmichael JD; Weiss M; Zada G
J Neurosurg; 2021 May; 135(6):1706-1713. PubMed ID: 33962375
[TBL] [Abstract][Full Text] [Related]
5. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
Sasagawa Y; Tachibana O; Nakagawa A; Koya D; Iizuka H
J Clin Neurosci; 2015 Mar; 22(3):601-3. PubMed ID: 25455737
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].
Hernandez Morin N; Huet D; Hautecouverture M
Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066
[TBL] [Abstract][Full Text] [Related]
7. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.
Langlois F; Lim DST; Yedinak CG; Cetas I; McCartney S; Cetas J; Dogan A; Fleseriu M
Pituitary; 2018 Feb; 21(1):32-40. PubMed ID: 29032459
[TBL] [Abstract][Full Text] [Related]
8. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
[TBL] [Abstract][Full Text] [Related]
9. Pituitary Adenoma With Apoplexy Presenting As Unilateral Third Nerve Palsy.
Waqar F; Arif A; Muazzam A; Khan A
Cureus; 2023 Jun; 15(6):e40555. PubMed ID: 37465780
[TBL] [Abstract][Full Text] [Related]
10. Sudden death in custody due to pituitary apoplexy during long restriction in a sitting position: a case report and review of the literature.
Sun T; Liu L; Sunnassee A; Zhuo L; Zhu S
J Forensic Leg Med; 2013 Oct; 20(7):812-5. PubMed ID: 24112326
[TBL] [Abstract][Full Text] [Related]
11. Acute Sterile Meningitis as a Primary Manifestation of Pituitary Apoplexy.
Tumyan G; Mantha Y; Gill R; Feldman M
AACE Clin Case Rep; 2021; 7(2):117-120. PubMed ID: 34095467
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of a 72-year-old patient with headache, hyponatremia and oculomotor nerve palsy: a case report and literature review.
Huang H; Jiang S; Yang C; Deng K; Wang R; Bao X
Gland Surg; 2021 Jan; 10(1):364-370. PubMed ID: 33633993
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
[TBL] [Abstract][Full Text] [Related]
14. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
Raj R; Elshimy G; Jacob A; Arya PVA; Unnikrishnan DC; Correa R; Myint ZW
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2337-2347. PubMed ID: 34156518
[TBL] [Abstract][Full Text] [Related]
15. Dissociated hypopituitarism after spontaneous pituitary apoplexy in acromegaly.
Mir SA; Masoodi SR; Bashir MI; Wani AI; Farooqui KJ; Kanth B; Bhat AR
Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S102-4. PubMed ID: 24251123
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature.
Hands KE; Alvarez A; Bruder JM
Endocr Pract; 2007 Oct; 13(6):642-6. PubMed ID: 17954421
[TBL] [Abstract][Full Text] [Related]
17. Giant necrotic pituitary apoplexy.
Fanous AA; Quigley EP; Chin SS; Couldwell WT
J Clin Neurosci; 2013 Oct; 20(10):1462-4. PubMed ID: 23623615
[TBL] [Abstract][Full Text] [Related]
18. Pituitary tumor apoplexy in patients with Cushing's disease: endocrinologic and visual outcomes after transsphenoidal surgery.
Choudhry OJ; Choudhry AJ; Nunez EA; Eloy JA; Couldwell WT; Ciric IS; Liu JK
Pituitary; 2012 Sep; 15(3):428-35. PubMed ID: 21927887
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.
Langlois F; Lim DST; Varlamov E; Yedinak CG; Cetas JS; McCartney S; Dogan A; Fleseriu M
Endocrine; 2017 Dec; 58(3):528-534. PubMed ID: 29043561
[TBL] [Abstract][Full Text] [Related]
20. Acute hypopituitarism associated with periorbital swelling and cardiac dysfunction in a patient with pituitary tumor apoplexy: a case report.
Ohara N; Yoneoka Y; Seki Y; Akiyama K; Arita M; Ohashi K; Suzuki K; Takada T
J Med Case Rep; 2017 Aug; 11(1):235. PubMed ID: 28835258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
